Blog

Jan 12, 2025, 20:06

Giuseppe Buono: Current status and future perspective of CAR-T cell therapy for breast cancer

Giuseppe Buono, Clinical and Translational Research Unit in Breast Cancer, IRCCS F. Pascale, Naples, shared on LinkedIn:

“Very proud to share our latest work exploring current status and future perspective of CAR-T cell therapy for breast cancer. Herein, provide an up-to-date overview of both preclinical and clinical data on the application of CAR-T cell therapy in BC, discussing the prevailing constrains of this approach and possible strategies to advance it. Take a look and share it with your community!”

CAR-T cell therapy for breast cancer: Current status and future perspective – ScienceDirect

Authors: Giuseppe Buono, Monica Capozzi, Roberta Caputo, Vincenzo Di Lauro, Daniela Cianniello, Michela Piezzo, Stefania Cocco, Claudia Martinelli, Annarita Verrazzo, Margherita Tafuro, Claudia Calderaio, Alessandra Calabrese, Francesco Nuzzo, Martina Pagliuca, Michelino De Laurentiis.

Alessandra Calabrese Annarita Verrazzo cancer Claudia Calderaio Claudia Martinelli Daniela Cianniello Francesco Nuzzo Giuseppe Buono Margherita Tafuro Martina Pagliuca Michela Piezzo Michelino De Laurentiis Monica Capozzi OncoDaily Oncology Roberta Caputo Stefania Cocco Vincenzo Di Lauro

ACT for Children: Tackling Inequities in Childhood Cancer Through Unique Global Collaboration

Richard Gere and Alejandra Gere to Join Second Global OncoThon on February 15 for Fight Against Childhood Cancer

Mesothelioma Guideline Updates from ASCO 2024: Key Advances in Diagnosis and Treatment

Oncologist Near Me - Lynn Schuchter: A Pioneering Leader in Cancer Care and Melanoma Research

NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%